IP Case Law › Patents › Intra-Cellular Therapies, Inc. v. The Controller of Patents
Relevant Acts and provisions
Patents Act, 1970
Section 2(1)(j)Section 2(1)(ja)Section 3(d)
Provisions considered: Sections 2(1)(j), 2(1)(ja) and 3(d) of the Patents Act, 1970 (as amended).
Brief facts
The Appellant applied for a patent for an invention titled 'ORGANIC COMPOUNDS', involving specific deuterated versions of chemical structures called heterocycle-fused gamma-carbolines, designed for the treatment of diseases involving receptor signalling systems in the brain (such as the 5-HT2A, SERT and dopamine receptors).
Free to read once you are signed in
Read the rest of this case note
The findings, the decision and the principle the court settled on are below. Create a free account to keep reading. No payment, and nothing to cancel.
Already have an account? Sign in
We use your details to give you access and to contact you about your enquiry. See our privacy policy.
Cases cited
- Novartis AG v. Union of India & Ors., (2013) 6 SCC 1
Authorities referred to in the decision. Please verify each citation in the judgment itself.
Keywords
Deuterated Compounds Heterocycle-fused Gamma-carbolines Parent Drug Exposure Pharmacological Activity Section 3(d) Therapeutic Efficacy
Read the judgment
More Patents judgments
Patents
Array Biopharma Inc v. Deputy Controller of Patents and Designs
A combination of distinct and independent active drugs, each with its own chemical identity and mechanism, does not fall under the Section 3(d) bar for derivatives of known substances. Using phrases such as 'for simultaneous, sepa…
Inventive StepMethod of TreatmentPharmaceutical CombinationPrior ArtPatentsBayer Corporation v. Union of India & Ors.
A compulsory licence under Section 84 of the Patents Act, 1970 may be granted where the reasonable requirements of the public with respect to a patented invention have not been satisfied, the invention is not available at a reason…
Compulsory LicencePublic HealthReasonably Affordable PriceSection 84PatentsBigtec Private Limited v. Assistant Controller of Patents and Designs
An objection that devising nucleotide probes or primers is routine experimentation lacking inventive step under Section 2(1)(ja) must engage with evidence of unexpected effects placed on record; and the Section 3(c) exclusion for …
BiotechnologyInventive StepPatent ProsecutionPrior Art